169 related articles for article (PubMed ID: 32123579)
1. NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2.
Ding D; Huang H; Li Q; Yu W; Wang C; Ma H; Wu J; Dang Y; Yu L; Jiang W
Cell Death Discov; 2020; 6():3. PubMed ID: 32123579
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability.
Jiang W; Huang H; Ding L; Zhu P; Saiyin H; Ji G; Zuo J; Han D; Pan Y; Ding D; Ma X; Zhang Y; Wu J; Yi Q; Liu JO; Huang H; Dang Y; Yu L
Oncogene; 2015 Aug; 34(34):4460-70. PubMed ID: 25399696
[TBL] [Abstract][Full Text] [Related]
3. IL-2 mRNA stabilization upon PMA stimulation is dependent on NF90-Ser647 phosphorylation by protein kinase CbetaI.
Zhu P; Jiang W; Cao L; Yu W; Pei Y; Yang X; Wan B; Liu JO; Yi Q; Yu L
J Immunol; 2010 Nov; 185(9):5140-9. PubMed ID: 20870937
[TBL] [Abstract][Full Text] [Related]
4. Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular Carcinoma.
Higuchi T; Todaka H; Sugiyama Y; Ono M; Tamaki N; Hatano E; Takezaki Y; Hanazaki K; Miwa T; Lai S; Morisawa K; Tsuda M; Taniguchi T; Sakamoto S
J Biol Chem; 2016 Sep; 291(40):21074-21084. PubMed ID: 27519414
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LINC00470 promotes proliferation through association with NF45/NF90 complex in hepatocellular carcinoma.
Huang W; Liu J; Yan J; Huang Z; Zhang X; Mao Y; Huang X
Hum Cell; 2020 Jan; 33(1):131-139. PubMed ID: 31612313
[TBL] [Abstract][Full Text] [Related]
6. Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in response to CD28 costimulation.
Pei Y; Zhu P; Dang Y; Wu J; Yang X; Wan B; Liu JO; Yi Q; Yu L
J Immunol; 2008 Jan; 180(1):222-9. PubMed ID: 18097023
[TBL] [Abstract][Full Text] [Related]
7. Aberrant USP11 expression regulates NF90 to promote proliferation and metastasis in hepatocellular carcinoma.
Zhang C; Xie C; Wang X; Huang Y; Gao S; Lu J; Lu Y; Zhang S
Am J Cancer Res; 2020; 10(5):1416-1428. PubMed ID: 32509388
[TBL] [Abstract][Full Text] [Related]
8. NF90 regulates PARP1 mRNA stability in hepatocellular carcinoma.
Song D; Huang H; Wang J; Zhao Y; Hu X; He F; Yu L; Wu J
Biochem Biophys Res Commun; 2017 Jun; 488(1):211-217. PubMed ID: 28487110
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth.
Lin WR; Lai MW; Yeh CT
Oncol Rep; 2013 Mar; 29(3):903-10. PubMed ID: 23292002
[TBL] [Abstract][Full Text] [Related]
10. TMEM98 mRNA promotes proliferation and invasion of gastric cells by directly interacting with NF90 protein.
Ao X; Li X; Chen Y; Zang Z; Guo W; Liang J
Cell Biol Int; 2020 Sep; 44(9):1820-1830. PubMed ID: 32379372
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
[TBL] [Abstract][Full Text] [Related]
12. Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour Progression.
Sonntag R; Penners C; Kohlhepp M; Haas U; Lambertz D; Kroh A; Cramer T; Ticconi F; Costa IG; Tacke F; Gassler N; Trautwein C; Liedtke C
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830835
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
14. The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.
Cheng CW; Leong KW; Ng YM; Kwong YL; Tse E
J Biol Chem; 2017 Dec; 292(52):21431-21441. PubMed ID: 29118189
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
[TBL] [Abstract][Full Text] [Related]
16. Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo.
Cho SJ; Lee SS; Kim YJ; Park BD; Choi JS; Liu L; Ham YM; Moon Kim B; Lee SK
Cancer Lett; 2010 Jan; 287(2):196-206. PubMed ID: 19616371
[TBL] [Abstract][Full Text] [Related]
17. Cyclin Y binds and activates CDK4 to promote the G1/S phase transition in hepatocellular carcinoma cells via Rb signaling.
Chen L; Wang X; Cheng H; Zhang W; Liu Y; Zeng W; Yu L; Huang C; Liu G
Biochem Biophys Res Commun; 2020 Dec; 533(4):1162-1169. PubMed ID: 33039146
[TBL] [Abstract][Full Text] [Related]
18. HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G
Lei Y; Xu X; Liu H; Chen L; Zhou H; Jiang J; Yang Y; Wu B
Autophagy; 2021 Dec; 17(12):4423-4441. PubMed ID: 33866937
[TBL] [Abstract][Full Text] [Related]
19. A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export.
Li C; Andrake M; Dunbrack R; Enders GH
Mol Cell Biol; 2010 Jan; 30(1):116-30. PubMed ID: 19858290
[TBL] [Abstract][Full Text] [Related]
20. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
Tsukada Y; Tanaka T; Miyazawa K; Kitamura N
J Biochem; 2004 Nov; 136(5):701-9. PubMed ID: 15632311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
